All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. Quality indicators for the management of lung cancer

    KCE Reports 266 (2016)

    https://kce.fgov.be/en/quality-indicators-for-the-management-of-lung-cancer

  2. Guideline on the management of rectal cancer

    KCE Reports 260 (2016)

    https://kce.fgov.be/en/guideline-on-the-management-of-rectal-cancer

  3. Oropharyngeal, hypopharyngeal and laryngeal cancer: diagnosis, treatment and follow-up

    KCE Reports 256 (2015)

    https://kce.fgov.be/en/oropharyngeal-hypopharyngeal-and-laryngeal-cancer-diagnosis-treatment-and-follow-up

  4. Ovarian cancer: diagnosis, treatment and follow-up

    KCE Reports 268 (2016)

    https://kce.fgov.be/en/ovarian-cancer-diagnosis-treatment-and-follow-up

  5. Renal cancer in adults: diagnosis, treatment and follow-up

    KCE Reports 253 (2015)

    https://kce.fgov.be/en/renal-cancer-in-adults-diagnosis-treatment-and-follow-up

  6. Bladder cancer: an assessment of international practice guidelines

      KCE Reports 247 (2015) Bladder cancer: diagnosis and management - ‘This document was published by the National Collaborating Centre for Cancer in 2015 and commissioned by the National Institute for Health and Care Excellence (NICE). The original publication is available from http://www.nice.org.uk/guidance/ng2 NICE guidance is prepared for the National Health Service in England and Wales. NICE has not been involved in the development or adaptation of any guidance for use in Belgium.’  

    https://kce.fgov.be/en/bladder-cancer-an-assessment-of-international-practice-guidelines

  7. Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2

    KCE Reports 243 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-diagnosis-and-follow-up-in-birt-hogg-dub%C3%A9-syndrome-familial-atypical-multiple

  8. Oncogenetic testing for persons with hereditary endocrine cancer syndromes

    KCE Reports 242 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-for-persons-with-hereditary-endocrine-cancer-syndromes

  9. Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology

    KCE Reports 240 (2015)

    https://kce.fgov.be/en/next-generation-sequencing-gene-panels-for-targeted-therapy-in-oncology-and-haemato-oncology

  10. Ten years of multidisciplinary teams meetings in oncology: current situation and perspectives

    KCE Reports 239 (2015)

    https://kce.fgov.be/en/ten-years-of-multidisciplinary-teams-meetings-in-oncology-current-situation-and-perspectives

  11. Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening

    KCE Reports 238 (2015)

    https://kce.fgov.be/en/cervical-cancer-screening-program-and-human-papillomavirus-hpv-testing-part-ii-update-on-hpv-primary

  12. Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment

    KCE Reports 237 (2015)

    https://kce.fgov.be/en/gene-expression-profiling-and-immunohistochemistry-tests-for-personalised-management-of-adjuvant

  13. Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li Fraumeni syndrome and Cowden syndrome

    KCE Reports 236 (2015)

    https://kce.fgov.be/en/oncogenetic-testing-and-follow-up-for-women-with-familial-breastovarian-cancer-li-fraumeni-syndrome

  14. Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers

    KCE Reports 235 (2015)

    https://kce.fgov.be/en/hadron-therapy-in-children-%E2%80%93-an-update-of-the-scientific-evidence-for-15-paediatric-cancers

  15. Oral cavity cancer: diagnosis, treatment and follow-up

    KCE Reports 227 (2014)

    https://kce.fgov.be/en/oral-cavity-cancer-diagnosis-treatment-and-follow-up

  16. National practice guideline on the treatment of localised prostate cancer – part 2

    KCE Reports 226 (2014)

    https://kce.fgov.be/en/national-practice-guideline-on-the-treatment-of-localised-prostate-cancer-%E2%80%93-part-2

  17. A decision aid for an informed choice when patient asks for PSA screening

    KCE Reports 224 (2014)

    https://kce.fgov.be/en/a-decision-aid-for-an-informed-choice-when-patient-asks-for-psa-screening

  18. Oncogenetic testing for Lynch syndrome and familial adenomatous polyposis

    KCE Reports 220 (2014)

    https://kce.fgov.be/en/oncogenetic-testing-for-lynch-syndrome-and-familial-adenomatous-polyposis

  19. Organisation of care for adults with rare cancers and cancers with complex diagnosis and/or treatment

    KCE Reports 219 (2014) Concrete proposals formulated by 14 multidisciplinary working groups including clinical experts and pathologists are provided in the Supplement to the report: Rare haematological cancers Cancers of the central nervous system Cancers of the head and neck Cancers of the endocrine organs - endocrine neoplasms Cancers of the endocrine organs - rare thyroïd cancer Neuroendocrine tumours (NETS) Malignant pleural mesothelioma Rare cancers of the female genital system Cancers occurring during pregnancy Cancers of the oesophagus Cancers of the pancreas Rare hepa

    https://kce.fgov.be/en/organisation-of-care-for-adults-with-rare-cancers-and-cancers-with-complex-diagnosis-andor-treatment

  20. Colon Cancer: Diagnosis, Treatment and Follow-Up

    KCE Reports 218 (2014) Via the following link, you have access to the KCE report on oncogenetic testing for Lynch syndrome and familial adenomatous polyposis, published in February 2014 (KCE report 220).

    https://kce.fgov.be/en/colon-cancer-diagnosis-treatment-and-follow-up

Pages